We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Testing Personalized Treatments in 5 Days With 3D

News   May 22, 2019 | Original story from University of Geneva (UNIGE)

 
Testing Personalized Treatments in 5 Days With 3D

Representative image of 3D model of colorectal carcinoma (HCT116 cells) exposed for 72 hours to treatment with a three-drug combination containing regorafenib, erlotinib and 5-fluorouracil. The cell-tracker stained cells correspond to cell nuclei (blue), live cells (green) and dead cells (red). © UNIGE, Molecular Pharmacology Group

 
 
 

RELATED ARTICLES

Biodegradable Nerve Guide Helps Regenerate Damaged Nerves

News

Scientists have created a biodegradable nerve guide consisting of a polymer tube filled with a growth-promoting protein, glial cell-derived neurotrophic factor, or GDNF. The results in nonhuman primate studies are promising.

READ MORE

CRISPR Cuts Open New Avenues in CAR T-cell Therapy

News

According to a study published in the Blood journal, drug profiling and the CRISPR-Cas9 gene editing method have opened new avenues in the development of CAR T-cell therapy, used to treat leukaemia and lymphoma.

READ MORE

Long-hidden Metabolic System Unlocks Cancer Secrets

News

Researchers have identified a long-hidden metabolic system in cells, which could provide a new opportunity to find ways to suppress cell proliferation in cancer.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE